Domov › Rakovina vaječníkov › Kolumbijský okres › Washington
Klinické štúdie Rakovina vaječníkov v meste Washington, DC
23 štúdií pre Rakovina vaječníkov hľadá účastníkov v zariadeniach v meste Washington a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Walter Reed National Military Medical Center, Bethesda · 7 míľ odtiaľ
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Prebieha náborFáza 2
- Walter Reed National Military Medical Center, Bethesda · 7 míľ odtiaľ
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
Prebieha náborFáza 1
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Prebieha náborFáza 1
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Prebieha náborFáza 2
- Holy Cross Hospital /ID# 275872, Silver Spring · 7 míľ odtiaľ
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)
Prebieha náborFáza 3
- MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Prebieha náborFáza 1
- Georgetown University Medical Center, Washington D.C.
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Prebieha náborFáza 3
- Holy Cross Hospital, Silver Spring · 7 míľ odtiaľ
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Prebieha náborFáza 2
- Medstar Georgetown University Hospital, Washington D.C.
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Prebieha náborFáza 3
- Holy Cross Hospital, Silver Spring · 7 míľ odtiaľ
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Prebieha náborFáza 1/2
- Children's National Medical Center, Washington D.C.
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Prebieha náborFáza 1
- Normunity Investigational Site, Washington D.C.
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
Prebieha náborFáza 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Prebieha náborFáza 2
- USA11-0, Bethesda · 7 míľ odtiaľ
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Cancer Support Community Research & Training Institute, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Silver Spring · 7 míľ odtiaľ
- Massive Bio SYNERGY-AI site, Bethesda · 7 míľ odtiaľ
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Prebieha náborVítaní zdravých dobrovoľníkov
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Prebieha náborFáza 1
- Holy Cross Hospital, Silver Spring · 7 míľ odtiaľ
Štúdie Rakovina vaječníkov v iných mestách
- Houston, TX89 štúdií
- New York City, NY69 štúdií
- Boston, MA61 štúdií
- Los Angeles, CA50 štúdií
- Nashville, TN49 štúdií
- Arlington, VA46 štúdií
- Philadelphia, PA44 štúdií
- Columbus, OH39 štúdií
- St. Louis, MO38 štúdií
- Chicago, IL36 štúdií
- San Antonio, TX31 štúdií
- Cleveland, OH30 štúdií
Iné štúdie v Washington
- Rakovina (všetky typy)58 štúdií
- Nemalobunkový karcinóm pľúc55 štúdií
- Rakovina prsníka46 štúdií
- Metastatická rakovina43 štúdií
- Rakovina pľúc41 štúdií
- Rakovina prostaty38 štúdií
- Obézita33 štúdií
- Kolorektálny karcinóm29 štúdií
- Kardiovaskulárne ochorenia28 štúdií
- Rakovina močového mechúra26 štúdií
- Akútna myeloidná leukémia24 štúdií
- Lymfóm23 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.